Back
  1. Home
  2. Profile of Sébastien Charron (UMONS)
Profil

Charron Sébastien

Main Referenced Co-authors
BELAYEW, Alexandra  (32)
COPPEE, Frédérique  (30)
Laoudj-Chenivesse, Dalila (18)
Ansseau, Eugénie  (16)
TASSIN, Alexandra  (15)
Main Referenced Keywords
FSHD (2); Atrophy (1); FOXO1 (1); WNT (1);
Main Referenced Unit & Research Centers
CREMH - Mind & Health (6)
Main Referenced Disciplines
Biotechnology (29)
General & internal medicine (22)
Zoology (8)
Phytobiology (plant sciences, forestry, mycology...) (1)

Publications (total 35)

The most downloaded
21 downloads
Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4 https://hdl.handle.net/20.500.12907/32904

The most cited

140 citations (Scopus®)

Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820 https://hdl.handle.net/20.500.12907/3115

Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4
Peer reviewed

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (16 November 2016). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. Bioforum, Liège Ulg , Unknown/unspecified.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (23 September 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (10 March 2015). Study of atrophy in Facioscapulohumeralmuscular dystrophy (FSHD) [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Carnac, G., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (17 October 2014). WNT pathway alterations in FSHD [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Vancutsem, K., Charron, S., Belayew, A., & Coppée, F. (08 July 2014). Study of atrophy in Facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France.

Charron, S., Vancutsem, K., Vanderplanck, C., Lancelot, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (14 May 2014). WNT pathway alterations in FSHD [Poster presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy.

Ansseau, E., Charron, S., Laoudj-Chenivesse, D., Coppée, F., & Belayew, A. (21 October 2013). Interplay between Sp1, YY1 and MYOD in transcription regulation of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Paper presentation]. FSH Society (FacioScapuloHumeral Muscular Dystrophy) International Reasearch Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts.

Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x
Peer reviewed

Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype [Poster presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States.

Charron, S., Vanderplanck, C., Vancutsem, K., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (25 September 2012). Facioscapulohumeral dystrophy: focus on the WNT perturbation [Poster presentation]. EMBO Meeting, Nice, France.

Charron, S. (18 June 2012). Etude du développement du muscle dans la FSHD [Poster presentation]. Doctoriales Franco-Belges, Mont Saint-Aubert, Belgium.

Charron, S., Dhont, L., & Belayew, A. (2012). « De la cellule à l'ADN ».

Charron, S., Belayew, A., & Coppée, F. (29 November 2011). WNT et FOXO dans la FSHD [Paper presentation]. Merci Téléthon, Forchie-la-marche, Belgium.

Charron, S., Vanderplanck, C., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (07 November 2011). Perturbation of the WNT signaling pathway in FSHD [Paper presentation]. FSH Society (FSHD) 2011 International Research Consortium and Researchplanning meetings, Boston, United States - Massachusetts.

Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? [Poster presentation]. FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820
Peer reviewed

Charron, S., Belayew, A., & Coppée, F. (29 October 2011). La signalisation cellulaire WNT et FOXO [Paper presentation]. Assemblée générale de l'association Amis FSH Europe, Agde, France.

Dmitriev, P., Petrov, A., Ansseau, E., Stankevicins, L., Charron, S., Kim, E., Bos, T., Robert, T., Turki, A., Coppée, F., Belayew, A., Lazar, V., Carnac, G., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (21 September 2011). The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy. Journal of Biological Chemistry, 286, 44620-44631.
Peer Reviewed verified by ORBi

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade [Poster presentation]. 4th international congress of myology 2011, Lille , France.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd [Paper presentation]. 4th international congress of myology 2011, Lille , France.

Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (12 May 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. 4th international congress of myology 2011, Lille , France.

Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD [Paper presentation]. 7th AGTS Meeting, Melbourne, Australia.

Ansseau, E., Charron, S., Guiguen, A., Van Lint, C., Coppée, F., & Belayew, A. (22 March 2011). YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD) [Poster presentation]. La matinée des chercheurs, Mons, Unknown/unspecified.

Charron, S. (22 March 2011). Study of muscle atrophy and development in FSHD [Poster presentation]. 6ème édition de la Matinée des Chercheurs (MDC 2011), Mons, Belgium.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD [Paper presentation]. MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada.

Charron, S., & Belayew, A. (2011). Visite Guidée du Laboratoire de Biologie Moléculaire.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. FSHD International Research Consortium Meeting, Boston, United States - Massachusetts.

Charron, S., & Tassin, A. (27 February 2010). Contribution à l'étude de la FSHD [Paper presentation]. Troisième journée sur les Maladies Rares, Radiorg, Bruxelles, Belgium.

Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts.
Editorial reviewed

Dmitriev, P., Petrov, A., Ansseau, E., Charron, S., Coppée, F., Belayew, A., Carnac, G., Turki, A., Laoudj-Chenivesse, D., Lipinski, M., & Vassetzky, Y. (06 November 2009). Kruppel-like factor KLF15 interacts with the D4Z4 enhancer and upregulates a FSHD-related gene DUX4c [Poster presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts.

Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles.

Charron, S., Vanderplanck, C., Belayew, A., & Coppée, F. (17 October 2009). WNT and FOXO signaling pathways in FSHD [Poster presentation]. Protein modifications in development and diseases, Liège, Belgium.

Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. International Symposium Signal transduction and disease, Aachen, Germany.
Editorial reviewed

Contact ORBi UMONS